February 13, 2024 · Form 4 insider transaction
GORMAN KEVIN CHARLES bought 2,312 shares of Neurocrine Biosciences, Inc. at $43.24 per share, a transaction worth $100.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.; 491,365 of the outstanding shares are held by the Gorman and Blais Family Trust, of which Dr. Gorman has voting and investment power.